Crossmark

Vaccine wastage in The Gambia: a prospective observational study

Crossref DOI link: https://doi.org/10.1186/s12889-018-5762-5

Published Online: 2018-07-11

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Usuf, Effua http://orcid.org/0000-0002-6515-7186
Mackenzie, Grant

Ceesay, Lamin

Sowe, Dawda

Kampmann, Beate

Roca, Anna
Funding

Funding for this research was provided by:

WHO TDR (B40129)
License Information

Text and Data Mining valid from 2018-07-11
More Information

Article History

Received: 9 February 2018

Accepted: 26 June 2018

First Online: 11 July 2018

Ethics approval and consent to participate

: The study was approved by the Medical Research Council Unit The Gambia - Gambia Government Joint Ethics Committee and the WHO Ethical Review Committee. The Ministry of Health endorsed the study and individual written informed consent was obtained from all participants. To ensure confidentiality unique identification codes were used for facilities and participants.

: NA

: EU had a consultancy with the GSK Malaria vaccine group that ended Dec 2017. All other authors declared that they have no competing interest.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.